Search

East Anglia-based infection control firm celebrates strong growth

PUBLISHED: 07:49 18 July 2018 | UPDATED: 07:49 18 July 2018

The entrance toTristel's facility at Snailwell, Newmarket Picture: BRUCE HEAD

The entrance toTristel's facility at Snailwell, Newmarket Picture: BRUCE HEAD

Bruce Head.bruce@brucehead.com

An infection control firm based near Newmarket is showing strong growth across the business.

Tristel endoscope products Picture: TRISTELTristel endoscope products Picture: TRISTEL

Tristel plc said it expected its results for the year ended June 30, 2018, will be in line with expectations, with a record turnover of £22.2m compared with £20.3m in 2017 and pre-tax profit of at least £4.4m, up from £4.1m in 2017.

Revenue from overseas markets contributed 51.3% of the group total, bringing it to a record level.

Chairman Francisco Soler who has announced his retirement at the forthcoming annual general meeting in December, said since he re-took the helm in 2014, he had presided over a “truly transformational” period and shareholders had benefited greatly. “It has taken a long time for the company to emerge as the globally recognised force in infection prevention it is today,” he said. “The board and management’s vision for the company today is very different from our view in 2014.”

Tristel's chief executive Paul Swinney and chief financial officer Liz Dixon Picture: GREGG BROWNTristel's chief executive Paul Swinney and chief financial officer Liz Dixon Picture: GREGG BROWN


If you value what this story gives you, please consider supporting the East Anglian Daily Times. Click the link in the orange box above for details.

Become a supporter

This newspaper has been a central part of community life for many years. Our industry faces testing times, which is why we're asking for your support. Every contribution will help us continue to produce local journalism that makes a measurable difference to our community.

Latest from the East Anglian Daily Times